Patent ID: 9415015
Filing Date: 2016-08-16
CPC Classification: A61J,A61K,A61P,B65D,G01N

Claim Text:
1. A fast-dispersing, solid, non-compressed oromucosal dosage form suitable for sublingual administration for alleviating symptoms to allergen induced allergy in an individual comprising: a lyophilized network formed from a solution comprising 1-10% W/W mannitol, 2-10% W/W fish gelatin, wherein said dosage form is packaged in a blister pack and comprises an allergen extract content of 2.5 μg-3.75 mg, wherein said allergen is selected from the group consisting of grass pollen allergen, house dust mite allergen, and ragweed pollen allergen and wherein the allergen extract content is effective for inducing an immune response in said individual wherein the loss of the allergen content in said dosage form is less than 50% of the initial allergen content after being held for 3 months at 25° C. and 60% relative humidity, and the loss of allergen content from said solid dosage form is less than 0.5 μg allergen extract or less than 0.05 μg major allergen when subjected to a friability test after being held for 3 months at 25° C. and 60% relative humidity, and wherein the water content of the dry matter does not exceed 8% by weight.